⌘K

Login Start Free

Home/Filings/4/0001520138-21-000588

4//SEC Filing

Ahlem Clarence N. 4

Accession 0001520138-21-000588

CIK 0001580149other

View on SEC.gov Company Profile

Filed

Sep 27, 8:00 PM ET

Accepted

Sep 28, 6:13 PM ET

Size

12.0 KB

Accession

0001520138-21-000588

Insider Transaction Report

Form 4

Period: 2021-08-20

BIOVIE INC.BIVI

Ahlem Clarence N.

EVP Neuroscience Product Dev.

Transactions

Award
Stock Option (right to buy)
2021-08-20+124,167→ 124,167 total
Exercise: $7.74Exp: 2031-08-19→ COMMON STOCK (124,167 underlying)

Footnotes (1)

[F1]This option was 20% vested upon grant, with an additional 16% on each of the first five anniversaries of the grant.

Documents

2 files

Issuer

BIOVIE INC.

CIK 0001580149

Entity typeother

Related Parties

1

filerCIK 0001884599

Filing Metadata

Form type: 4
Filed: Sep 27, 8:00 PM ET
Accepted: Sep 28, 6:13 PM ET
Size: 12.0 KB

View on SEC.gov